Does the type of flu shot you get actually change how well it works?
Yes. In this trial, a high-dose recombinant flu vaccine produced antibody levels against the A(H3N2) strain nearly three times higher than standard egg-grown and cell-grown shots. Just as important, it kept working well even in people who get vaccinated every year.
Not all flu shots are made the same way. Most are grown in chicken eggs, some are grown in cells, and a newer type is built using recombinant technology, which means the vaccine is made from a purified copy of a flu protein rather than a whole grown virus. This study tested whether that difference matters, and it looks like it does.
What the data show
Researchers ran a randomized, double-blind trial with 366 healthy adults aged 21 to 49 in Singapore. Randomized means people were assigned to a vaccine by chance, and double-blind means neither the participants nor the researchers knew which shot each person got. That design helps remove bias and makes the results more trustworthy.
The high-dose recombinant vaccine, called QIV-R, generated antibody levels against the A(H3N2) strain that were nearly three times higher than the standard-dose egg-grown and cell-grown vaccines. Antibodies are the proteins your immune system makes to recognize and fight a virus, so higher levels generally mean stronger protection. This matters because A(H3N2) is the flu strain most closely linked to severe illness and hospital stays.
Dr. Kumar’s Take
What stands out to me here is not just the higher antibody levels, it is who kept those levels. For years we have known that getting the flu shot over and over can slightly dull your response to the next one. In this study, that dulling showed up with the egg-grown and cell-grown shots but not with the recombinant one. For anyone who dutifully gets a flu shot every single year, that is a real advantage. I want to be clear that this trial measured antibody levels, not whether fewer people actually caught the flu, so we should not oversell it. Still, it is a strong signal that how a vaccine is made can shape how well it works.
Why frequent vaccination changed the results
One of the most interesting findings was about vaccination history. People who had been vaccinated frequently in prior years mounted weaker responses to the egg-grown and cell-grown shots. Their immune systems seemed to react less strongly the more shots they had received over time.
The recombinant vaccine did not have this problem. Its responses stayed strong whether a person was vaccinated often or rarely. That consistency is valuable because the people most likely to get a yearly flu shot, such as older adults and those with health conditions, are exactly the ones who could lose some benefit from the blunting effect. A vaccine that sidesteps that issue could give steady protection year after year.
Safety and what to keep in mind
All three vaccines had similarly low rates of side effects, so the stronger response from the recombinant shot did not come with extra discomfort. That is reassuring, because a better immune response is only useful if people can tolerate the shot easily.
A few limits are worth noting. This was a single center study in Singapore with a specific age range of 21 to 49, so the results may not apply to everyone. It also measured antibody levels rather than counting real flu infections, which is the outcome that matters most in daily life. Larger trials that track who actually gets sick would help confirm whether these antibody gains translate into fewer flu cases.
Practical Takeaways
- If you get a flu shot every year, ask your doctor whether a recombinant flu vaccine is available to you, since this study suggests it may hold up better in frequent vaccine recipients.
- Do not skip your annual flu shot while waiting for the perfect option, because any current flu vaccine still lowers your risk of serious illness.
- Pay attention to the A(H3N2) strain in particular, as it is the one most linked to severe flu and hospital stays.
- Remember that higher antibody levels are promising but not a guarantee, so keep other habits like handwashing and staying home when sick as part of your defense.
Related Studies and Research
- Flu vaccine effectiveness: how well does it prevent severe illness in adults?
- New mRNA flu vaccine works better than standard flu shots in older adults
- Single-dose psilocybin vs placebo: first double-blind depression trial
- Single-dose psilocybin shows rapid, sustained antidepressant effects
FAQs
What is a recombinant flu vaccine and how is it different?
A recombinant flu vaccine is made using a purified copy of a flu protein instead of a whole virus grown in eggs or cells. Because it skips the egg-growing step, it avoids small changes that can happen when a flu virus is grown in eggs, which sometimes make the vaccine match the circulating strain less well. In this study, the high-dose recombinant version also produced much higher antibody levels against A(H3N2). That combination of a cleaner match and a stronger response is why researchers are paying close attention to it.
Why does getting a flu shot every year sometimes weaken the response?
Repeated flu vaccination can lead your immune system to react a little less strongly to each new shot, a pattern researchers have studied for years. Your body may lean on existing memory from past shots rather than mounting a fresh, full response. This study saw that blunting with the egg-grown and cell-grown vaccines but not with the recombinant one. That is why the type of vaccine you receive, and not just whether you get one, may matter for regular vaccine recipients.
Should I ask for the high-dose recombinant flu shot this year?
It is a reasonable question to raise with your doctor, especially if you get vaccinated every year. This trial found stronger and more consistent antibody responses with the high-dose recombinant vaccine, with side effect rates similar to the other shots. Keep in mind the study looked at antibody levels in adults aged 21 to 49 at one center, not real-world infection rates across all ages. Your doctor can weigh your age, health, and what vaccines are available locally to help you decide.
Bottom Line
In healthy adults, a high-dose recombinant flu vaccine produced antibody levels against the dangerous A(H3N2) strain nearly three times higher than standard egg-grown and cell-grown shots, and it kept working well even in people vaccinated frequently in the past. With side effects just as low as the other vaccines, this points toward a better protecting option for the flu strain most tied to severe illness. Larger studies tracking real infections will help confirm whether these stronger antibody responses lead to fewer people getting sick.
